www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.


 
November 8, 2005

Taro to Report Third Quarter 2005 Results and Conduct Conference Call on November 17, 2005

HAWTHORNE, N.Y., Nov 08, 2005 (BUSINESS WIRE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq: TARO) intends to report financial results for the third quarter of 2005 prior to the Nasdaq market opening on Thursday, November 17, 2005. The Company will conduct a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).

The call will be available live via the Internet by accessing www.taro.com.

Online and telephone replays of the call will be available from approximately 1:00 p.m. on November 17, 2005 through November 25, 2005. The online replay can be accessed at www.taro.com. The telephone replay can be heard by dialing 1-888-286-8010 (domestic U.S.) or +617-801-6888 (international). Please provide this passcode when prompted: 69447933.

Taro is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

For more information on Taro, please visit www.taro.com.

SOURCE: Taro Pharmaceutical Industries Ltd. 

Taro Pharmaceutical Industries 
Daniel Saks, 914-345-9000 ext. 6208                 
 or
Kevin Connelly, 914-345-9000 ext. 6338


Privacy Statement   |   Terms of Use   |   Safe Harbor Statement